Key result
Elevated tissue and plasma PCSK9 levels are associated with worse prognosis after colorectal liver metastasis resection.
Answers are grounded in this paper and cite their sources.
Case-control study shows PCSK9 expression predicts outcomes in colorectal liver metastases, suggesting clinical utility.
Our study indicates that both tissue and plasma PCSK9 expressions hold promise as prognostic biomarkers for curative-intent resection of CRLM.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question. Tissue and plasma PCSK9 expressions are promising prognostic biomarkers for patients undergoing curative-intent resection of colorectal liver metastases.
Synapse has enriched 10 related papers. Consider them for comparative context: